Morning Overview on MSN
The pancreatic-cancer pill is taken once a day and beat standard chemo in late-stage patients
Patients with previously treated metastatic pancreatic cancer who took an oral once-daily pill called daraxonrasib lived ...
Morning Overview on MSNOpinion
A once-a-day pill nearly doubled survival for patients with advanced pancreatic cancer in a 500-person trial
Patients with previously treated metastatic pancreatic cancer lived roughly twice as long when given an oral pill called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results